Use of serological assays for diagnosis of hepatitis e virus genotype 1 and 3 infections in a setting of low endemicity

Clinical and Vaccine Immunology

Volumn 14, Issue 5, 2007, Pages 562-568

  Herremans, M ^a,b   Bakker, J ^a   Duizer, E ^a   Vennema, H ^a   Koopmans, M P G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ORF3; UNCLASSIFIED DRUG; VIRUS PROTEIN; HEPATITIS ANTIBODY; RECOMBINANT PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; NETHERLANDS;

CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NETHERLANDS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 34250327144     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00231-06     Document Type: Article

References (19)

1. Aggarwal, R., and S. R. Naik. 1997. Epidemiology of hepatitis E: past, present and future. Trop. Gastroenterol. 18:49-56.
2. Balayan, M. S., A. G. Andjaparidze, S. S. Savinsaya, E. S. Ketiladze, D. M. Braginsky, A. P. Savinov, and V. F. Poleschuk. 1983. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20:23-31.
3. Clemente-Casares, P., S. Pina, M. Buti, R. Jardi, M. Martin, S. Bofill-Mas, and R. Girones. 2003. Hepatitis E virus epidemiology in industrialized countries. Emerg. Infect. Dis. 9:448-454.
4. Colac, D., D. Ogunc, F. Gunseren, S. Velipasaoglu, M. R. Aktekin, and M. Gultekin. 2002. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in turkey. Acta Microbiol. Immunol. Hung. 49:93-97.
5. Corwin, A. L., H. B. Khiem, E. T. Clayson, K. S. Pham, T. T. Vo, T. Y. Vu, T. T. Cao, D. Vaughn, J. Merven, T. L. Richie, M. P. Putri, J. He, R. Graham, F. S. Wignall, and K. C. Hyams. 1996. A waterborne outbreak of hepatitis E virus transmission in south-western Vietnam. Am. J. Trop. Med. Hyg. 54:559-562.
6. Daniel, H. D., A. Warier, P. Abraham, and G. Sridharan. 2004. Age-wise exposure rates to hepatitis E virus in a southern Indian patient population without liver disease. Am. J. Trop. Med. Hyg. 71:675-678.
7. Favorov, M. O., H. A. Fields, M. A. Purdy, T. L. Yashina, A. G. Aleksandrov, M. J. Alter, D. M. Yarasheva, D. W. Bradley, and H. S. Margolis. 1992. Serologic identification of hepatitis E virus infection in epidemic and endemic settings. J. Med. Virol. 36:246-250.
8. Herremans, M., H. Vennema, J. Bakker, B. van der Veer, E. Duizer, C. A. Benne, K. Waar, B. Hendrixks, P. Schneeberger, G. Blaauw, M. Kooiman, and M. P. G. Koopmans. 2007. Swine-like hepatitis E viruses are a cause of unexplained hepatitis in The Netherlands. J. Viral Hepatol. 14:140-146.
9. Jameel, S. 1999. Molecular biology and pathogenesis of hepatitis E virus. Expert Rev. Mol. Med. 6:1-16.
10. Mansuy, J. M., J. M. Peron, C. Bureau, L. Alric, J. P. Vinel, and J. Izopet. 2004. Immunologically silent autochthonous acute hepatitis E virus infection in France. J. Clin. Microbiol. 42:912-913.
11. Mizuo, H., Y. Yazaki, K. Sugawara, F. Tsuda, M. Takahashi, T. Nishizawa, and H. Okamoto. 2005. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J. Med. Virol. 76:341-349.
12. Obriadina, A., J. H. Meng, T. Ulanova, K. Trinta, A. Burkov, H. A. Fields, and Y. E. Khudyakov. 2002. A new enzyme immunoassay for the detection of antibody to hepatitis E virus. J. Gastroenterol. Hepatol. 17:S360-S364.
13. Schlauder, G. G., S. M. Desai, A. R. Zanetti, N. C. Tassopoulos, and I. K. Mushahwar. 1999. Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J. Med. Virol. 57:243-251.
14. Van der Poel, W. H. M., F. Verschoor, R. van der Heide, M. Kooreman, and A. M. de Roda Husman. 2001. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg. Infect. Dis. 7:970-976.
15. Waar, K., M. M. P. T. Herremans, H. Vennema, M. P. G. Koopmans, and C. A. Benne. 2004. Hepatitis E is a cause of unexplained hepatitis in The Netherlands. J. Clin. Virol. 33:145-149.
16. Widdowson, M.-A., W. J. M. Jaspers, W. H. M. van der Poel, F. Verschoor, A. M. de Roda Husman, H. L. J. Winter, H. L. Zaaijer, and M. Koopmans. 2003. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in The Netherlands. Clin. Infect. Dis. 36:29-33.
17. Zanetti, A. R., G. G. Schlauder, L. Romano, E. Tanzi, P. Fabris, G. J. Dawson, and I. K. Mushahwar. 1999. Identification of a novel variant of hepatitis E virus in Italy. J. Med. Virol. 57:356-360.
18. Zhang, J. Z., S. W. Im, S. H. Lau, T. N. Chau, S. T. Lai, S. P. Ng, M. Peiris, C. Tse, T. K. Ng, and M. H. Ng. 2002. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J. Med. Virol. 66:40-48.
19. Zhou, Y. H., R. H. Purcell, and S. U. Emerson. 2003. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotype 1, 2, 3, and 4. Vaccine 22:2578-2585.